X

Vous n'êtes pas connecté

Rubriques :

  - DRUGS.COM - Daily MedNews - 20/Jun 21:31

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

FRIDAY, June 20, 2025 -- The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa for prophylactic use to prevent attacks of hereditary angioedema (HAE). According to the Mayo...

Articles similaires

Sorry! Image not available at this time

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

drugs.com - 20/Jun 21:31

FRIDAY, June 20, 2025 -- The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa...

Sorry! Image not available at this time

FDA Approves Andembry (garadacimab-gxii) for Prophylaxis to Prevent Attacks of Hereditary Angioedema

drugs.com - 16/Jun 06:06

KING OF PRUSSIA, Pa., June 16, 2025 /PRNewswire/ -- Global biotechnology leader CSL today announced the U.S. Food and Drug Administration (FDA)...

Sorry! Image not available at this time

FDA Approves Andembry (garadacimab-gxii) for Prophylaxis to Prevent Attacks of Hereditary Angioedema

drugs.com - 16/Jun 06:06

KING OF PRUSSIA, Pa., June 16, 2025 /PRNewswire/ -- Global biotechnology leader CSL today announced the U.S. Food and Drug Administration (FDA)...

Sorry! Image not available at this time

New treatment for HAE, called garadacimab, approved in USA for the prevention of attacks of hereditary angioedema (HAE)

haei.org - 16/Jun 12:37

New treatment for HAE, called garadacimab, approved in USA for the prevention of attacks of hereditary angioedema (HAE) Garadacimab, a new HAE...

Sorry! Image not available at this time

New treatment for HAE, called garadacimab, approved in USA for the prevention of attacks of hereditary angioedema (HAE)

haei.org - 16/Jun 12:37

New treatment for HAE, called garadacimab, approved in USA for the prevention of attacks of hereditary angioedema (HAE) Garadacimab, a new HAE...

Sorry! Image not available at this time

FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma

drugs.com - 23/Jun 19:54

MONDAY, June 23, 2024 -- The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with...

Sorry! Image not available at this time

FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma

drugs.com - 23/Jun 19:54

MONDAY, June 23, 2024 -- The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with...

Sorry! Image not available at this time

U.S. FDA Approves Expanded Indication for AbbVie's Mavyret (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus

drugs.com - 11/Jun 23:06

NORTH CHICAGO, Ill., June 11, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved a...

Sorry! Image not available at this time

U.S. FDA Approves Expanded Indication for AbbVie's Mavyret (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus

drugs.com - 11/Jun 23:06

NORTH CHICAGO, Ill., June 11, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved a...

Sorry! Image not available at this time

FDA Approves Dupixent for Bullous Pemphigoid

drugs.com - 17:48

TUESDAY, June 24, 2025 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous...

Les derniers communiqués